Subsequently, we investigated the potential correlation between coexisting ARID1A-PIK3CA mutations and various clinicopathological parameters in luminal tumors, such as disease grade, tumor size, patient age, and overall survival. This evidence concerns the gene PIK3CA and neoplasm.